| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
77,921,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
4,773,204 |
Avg
Vol: |
2,204,032 |
| 52
Week Range: |
$81.49 - $81.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-10 |
4 |
S |
$78.55 |
$105,815 |
D/D |
(1,347) |
36,408 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-10 |
4 |
OE |
$48.20 |
$99,967 |
D/D |
2,074 |
37,209 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-10 |
4 |
D |
$78.49 |
$99,918 |
D/D |
(1,273) |
35,135 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-10 |
4 |
S |
$78.30 |
$2,033,907 |
D/D |
(25,918) |
70,375 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-10 |
4 |
OE |
$48.06 |
$2,528,163 |
D/D |
50,125 |
96,293 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-10 |
4 |
S |
$78.93 |
$315,837 |
D/D |
(4,000) |
35,250 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-10 |
4 |
S |
$78.61 |
$2,451,677 |
D/D |
(31,125) |
39,250 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-12-06 |
4 |
S |
$77.00 |
$1,855,700 |
D/D |
(24,100) |
17,156 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-12-06 |
4 |
OE |
$46.58 |
$1,141,006 |
D/D |
24,100 |
41,256 |
|
- |
|
| Vaught Jeffry L |
Exec. VP & Pres., R&D |
• – – |
2007-12-06 |
4 |
S |
$77.00 |
$5,390,456 |
D/D |
(70,000) |
55,757 |
|
- |
|
| Vaught Jeffry L |
Exec. VP & Pres., R&D |
• – – |
2007-12-06 |
4 |
OE |
$27.63 |
$3,345,325 |
D/D |
70,000 |
125,757 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-12-06 |
4 |
S |
$76.00 |
$1,520,068 |
D/D |
(20,000) |
72,837 |
|
- |
|
| Baldino Frank Jr |
Chairman & CEO |
• • – |
2007-12-03 |
4 |
D |
$74.50 |
$597,639 |
D/D |
(8,022) |
372,905 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2007-12-03 |
4 |
S |
$74.82 |
$374,358 |
D/D |
(5,000) |
0 |
|
- |
|
| Greenacre Martyn D |
Director |
– • – |
2007-12-03 |
4 |
OE |
$12.38 |
$61,875 |
D/D |
5,000 |
5,000 |
|
- |
|
| Vaught Jeffry L |
Exec. VP & Pres., R&D |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$84,185 |
D/D |
(1,130) |
55,757 |
|
- |
|
| Savini Carl A |
Exec. VP & CAO |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$86,271 |
D/D |
(1,158) |
46,168 |
|
- |
|
| Osborn John E |
Exec VP, General Counsel & Sec |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$112,123 |
D/D |
(1,505) |
37,495 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$113,464 |
D/D |
(1,523) |
41,353 |
|
- |
|
| Buchi J Kevin |
Exec. Vice President & CFO |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$120,467 |
D/D |
(1,617) |
92,837 |
|
- |
|
| Russell Lesley |
Exec. VP, WW Med & Reg Affairs |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$9,015 |
D/D |
(121) |
17,156 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-12-03 |
4 |
D |
$74.50 |
$84,185 |
D/D |
(1,130) |
37,755 |
|
- |
|
| Grebow Peter E |
Exec. VP, WW Technical Ops. |
• – – |
2007-11-29 |
4 |
S |
$74.80 |
$870,597 |
D/D |
(11,639) |
42,876 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-11-28 |
4 |
S |
$75.26 |
$395,877 |
D/D |
(5,255) |
38,885 |
|
- |
|
| Roche Robert P Jr |
Exec VP, WW Pharmaceutical Ops |
• – – |
2007-11-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
70 |
44,140 |
|
- |
|
491 Records found
|
|
Page 10 of 20 |
|
|
